<p>Tumor samples were collected from a patient with synovial sarcoma, which acquired resistance to ACT targeting NY-ESO-1. Biopsies (n=3; primary, metastasis, and recurrence) were subjected to bulk tumor DNA and RNA sequencing, as well as high-dimensional spatial profiling of RNA and protein targets. Bulk tumor whole exome and RNA sequencing corresponding to all three tumor specimens and whole exome sequencing from patient-matched normal blood are made available through this accession.</p>

Functional Multiomics of Cellular Therapy and Immune Checkpoint Blockade    Therapy for Solid Tumors

Adoptive Transfer study with RNA-Seq, SNP/CNV Genotypes (NGS) + 2 more data on dbGaP (1 participants)

Functional Multiomics of Cellular Therapy and Immune Checkpoint Blockade Therapy for Solid Tumors

Description

Applying For Access

Summary